The FDA's Pharmacy Compounding Advisory Committee met July 23-24 to consider whether 7 unapproved peptides—BPC-157, KPV, TB-500, MOTS-c, emideltide, epitalon, and semax—should be added to the agency's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results